🟢 Chimeric Therapeutics is trading 5% up today amid stronger biotech sentiment

Chimeric Therapeutics is trading at A$0.04, up +5.13%, amid stronger biotech sentiment.

• No new company-specific announcement, clinical update, earnings release, or broker action was identified for August 7, 2026.
• ASX and announcement listings showed no stronger fresh catalyst.
• The move appears consistent with heightened merger-and-acquisition activity supporting the sector, but this remains unconfirmed company-specific causation.